Results 101 to 110 of about 10,799 (115)

BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer. [PDF]

Breast
Guinel T, Lusque A, Mailliez A, Massard V, Jacot W, Guiu S, de la Motte Rouge T, Brain E, Desmoulins I, Arnedos M, Bailleux C, Goncalves A, Levy C, Bachelot T, Bosquet L, Delaloge S, Frénel JS.   +16 more
europepmc   +1 more source

Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors. [PDF]

Front Oncol
Hargrave D, Marshall LV, André N, Krystal J, Ladle BH, Robbins KA, Hois S, Armstrong J, Donegan S.   +8 more
europepmc   +1 more source

Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus study. [PDF]

Clin Transl Radiat Oncol
Thariat J, Beddok A, Salas S, Gorphe P, Doré M, Racadot S, Vozy A, Pointreau Y, Dupin C, Renard S, Mouawad F, Pereira S, Deneuve S, Blanchard P.   +13 more
europepmc   +1 more source

Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results. [PDF]

Tech Innov Patient Support Radiat Oncol
Ayadi M, Dupuis P, Sandt M, Beldjoudi G, Serre A, Martel-Lafay I, Claude L, Guimas V, Chiavassa S, Moignier A, Alexis A, Ollivier L, Vaugier L, Lange M, Moncharmont C, Sunyach MP.   +15 more
europepmc   +1 more source

Development and Assessment of a Pipeline for Extracting Structured Data From Free-Text Medical Reports Using a Large Language Model. [PDF]

JCO Clin Cancer Inform
Joseph E, Vallee P, Perennec T, Wagneur N, Frenel JS, Campone M, Bocquet F, Le Borgne F.   +7 more
europepmc   +1 more source

Non-canonical signaling hubs upon inhibition of MyD88-ERK interaction in cancer. [PDF]

Cell Death Dis
Hussein N, Skafi N, Pham TH, Gautier M, Virard F, Fauvet F, Magadoux L, Chassot-Lamblot C, Morel AP, Vanbelle C, Badran B, Lebecque S, Manié SN, Lamure S, Renno T, Coste I.   +15 more
europepmc   +1 more source

[Senegalese experience with volumetric modulated arc therapy in the treatment of locally advanced rectal adenocarcinoma: a retrospective study of 59 cases]. [PDF]

Pan Afr Med J
Ka K, Dieng MM, Edimo LEF, Ndong B, Boye AT, Thiaw G, Souho B, Touré AO, Gaye PM, Kassé AA.   +9 more
europepmc   +1 more source

Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61-FUNGEMAX trial (France). [PDF]

EClinicalMedicine
Taieb J, Pernot S, Thuillier F, Delattre A, Vo-Quang E, Petorin C, Bourgeois V, Tougeron D, Audemar F, Vitellius C, Mosser L, Desrame J, Di Fiore F, Rinaldi Y, Pellat A, Bolliet M, Watelle F, Perrier H, Dubreuil O, Lepage C, Bachet JB.   +20 more
europepmc   +1 more source

Advancing cancer care for adolescents and young adults: the role of the European Network of Expertise. [PDF]

ESMO Open
Ferrari A, Provenzano S, Prampolini C, van der Graaf W, Husson O, Morgan JD, Quarello P, Larrosa C, Heredia AC, Peccatori F, Stark D, Laurence V, Gaspar N, Poirel HA, Van Aelst F, Franceschi E, Saloustros E, Dirksen U, Kienesberger A, Schneider C, Murphy I, Kosir U, Rizvi K, Fiorente M, Casali P, Trama A.   +25 more
europepmc   +1 more source

Dosimetric Feasibility of Dose-Painting Radiation Therapy for Targeting Hypoxia in Prostate Cancer on a Novel Ring Gantry Radiation Therapy System. [PDF]

Adv Radiat Oncol
Perennec T, Al Feghali KA, de Jong D, Oderinde OM, Gibbard G, Dore M, Delpon G, Alexandra M, Seroux Y, Ferrer L, Hatt M, Rousseau C, Supiot S.   +12 more
europepmc   +1 more source